ES2091221T3 - Vacuna de citomegalovirus recombinante. - Google Patents

Vacuna de citomegalovirus recombinante.

Info

Publication number
ES2091221T3
ES2091221T3 ES90303108T ES90303108T ES2091221T3 ES 2091221 T3 ES2091221 T3 ES 2091221T3 ES 90303108 T ES90303108 T ES 90303108T ES 90303108 T ES90303108 T ES 90303108T ES 2091221 T3 ES2091221 T3 ES 2091221T3
Authority
ES
Spain
Prior art keywords
cytomegalovirus vaccine
recombinant cytomegalovirus
subunit
recombinant
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90303108T
Other languages
English (en)
Inventor
Stanley A Plotkin
Robert P Ricciardi
Eva Gonczol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Wistar Institute
Original Assignee
The Wistar Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wistar Institute filed Critical The Wistar Institute
Application granted granted Critical
Publication of ES2091221T3 publication Critical patent/ES2091221T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SISTEMA DE EXPRESION RECOMBINANTE DE ADENOVIRUS NO DEFECTUOSO QUE EXPRESA LA SUBUNIDAD DE LA GLUCOPROTEINA DE RECUBRIMIENTO PRINCIPAL DEL HCMV, PARA SU USO COMO VACUNA DE SUBUNIDAD CONTRA INFECCIONES POR CITOMEGALOVIRUS.
ES90303108T 1989-03-24 1990-03-22 Vacuna de citomegalovirus recombinante. Expired - Lifetime ES2091221T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32840689A 1989-03-24 1989-03-24

Publications (1)

Publication Number Publication Date
ES2091221T3 true ES2091221T3 (es) 1996-11-01

Family

ID=23280848

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90303108T Expired - Lifetime ES2091221T3 (es) 1989-03-24 1990-03-22 Vacuna de citomegalovirus recombinante.

Country Status (7)

Country Link
EP (1) EP0389286B1 (es)
AT (1) ATE140154T1 (es)
CA (1) CA2012895C (es)
DE (1) DE69027695T2 (es)
DK (1) DK0389286T3 (es)
ES (1) ES2091221T3 (es)
GR (1) GR3020765T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
WO1994023744A1 (en) * 1993-04-16 1994-10-27 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5820868A (en) * 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
US6448389B1 (en) 1996-04-23 2002-09-10 The Wistar Institute Of Anatomy And Biology Human cytomegalovirus DNA constructs and uses therefor
CA2594375C (en) 1997-06-23 2015-12-22 University Of Saskatchewan Bovine adenovirus type 3 genome
US6451319B1 (en) 1999-04-09 2002-09-17 Schering-Plough Veterinary Corporation Recombinant and mutant adenoviruses
JP2003534805A (ja) 2000-05-31 2003-11-25 ユニバーシティ オブ サスカチュワン 変化した親和性を有する改変ウシアデノウイルス

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
CA1335429C (en) * 1986-03-07 1995-05-02 Geoffrey L. Smith Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
EP0252531B1 (de) * 1986-06-12 1992-12-02 BEHRINGWERKE Aktiengesellschaft Strukturelles Phosphoprotein (pp 150) des menschlichen Cytomegalovirus, seine Herstellung und Verwendung
DE3619720A1 (de) * 1986-06-12 1987-12-17 Behringwerke Ag Hauptglykoprotein des menschlichen cytomegalovirus, seine herstellung und verwendung
DE3619902A1 (de) * 1986-06-13 1988-03-03 Biotechnolog Forschung Gmbh Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung
ZA878031B (en) * 1986-11-04 1988-04-28 Scripps Clinic And Research Foundation Nucleic acid probes for the detection of latent human cytomegalovirus in blood products
EP0277773A1 (en) * 1987-01-30 1988-08-10 The Board Of Trustees Of The Leland Stanford Junior University Hybrid cytomegalovirus (CMV) and vaccine

Also Published As

Publication number Publication date
CA2012895A1 (en) 1990-09-24
ATE140154T1 (de) 1996-07-15
CA2012895C (en) 2000-01-18
EP0389286A2 (en) 1990-09-26
DE69027695D1 (de) 1996-08-14
EP0389286B1 (en) 1996-07-10
GR3020765T3 (en) 1996-11-30
DE69027695T2 (de) 1997-02-20
DK0389286T3 (da) 1996-11-18
EP0389286A3 (en) 1991-06-12

Similar Documents

Publication Publication Date Title
ES2056817T5 (es) Transformacion de trichoderma.
ES8402946A1 (es) Un metodo de deteccion y alimentacion de una senal optica en una fibra optica, junto con un aparato correspondiente.
ES2155474T3 (es) Preparacion y uso de ratones transgenicos que carecen de la expresion de cd28.
FI923376A7 (fi) Precisionslandningssystem.
DK289285A (da) Thymopentin analoge
ES2110447T3 (es) Sistema de afeitado.
NO940782L (no) Anvendelse av rbedre fortykkere for vandige systemer
ES2193192T3 (es) Receptores de interleuquina-15.
DE3860476D1 (de) Landungssystem eines flugzeuges.
NL160091B (nl) Deflectiesysteem voor een lichtbundel, alsmede optisch systeem, waarbij de plaats van het focus geregeld wordt.
DE68924972D1 (de) Steuerungssystem des Antriebs eines Luftfahrzeugs.
NO854065L (no) B|rerem for v¨pen.
NO871051D0 (no) 1,1-disbustituerte cyklopropanderivater, fremgangsmaate til deres fremstilling samt deres anvendelse som antimykotika eller som mellomprodukter.
TR20227A (tr) Tekstil malzemesi uezerinde boya isleri ve baskilarin yapilmasi icin sabun yardimci maddeleri olarak ince zerreli,suda coezuelmeyen alkali aluminyum silikatlarinin kullanilmasi
ES2033273T3 (es) Procedimiento para la obtencion de terpolimeros.
IT8223119A0 (it) Dispositivo per la separazione di fasci di radiazioni emergenti da una fibra ottica.
ATE140154T1 (de) Rekombinanter cytomegalovirus-impfstoff
DK120701B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 17β-tetrahydropyranylethere af Δ<1,3,5(10)>-østratrien-3-ol-eller 3-ethere eller 3-estere deraf.
MX9206365A (es) Tetrahidrobenzotienopiridinas,proceso para su preparacion y composicion farmaceutica que las contiene
ES2111469B1 (es) Sistema de control para frenado de aeronave.
IT983728B (it) Regolatore di pressione per im pianto di frenatura ad aria com pressa
CA602362A (en) Hydraulic supply system for an aeronautical propeller or the like
FR1386780A (fr) Turbine à grande vitesse à entraînement par air, sous pression, notamment pour fraises de dentisterie
FR1498518A (fr) Système de réglage de la position des plaquettes nasales de lunettes
ES1008716Y (es) Bomba de practicas perfeccionada, apta para ser lanzada desde aeronaves.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 389286

Country of ref document: ES